RxDoctor Payments Data

Igor Altman, DO

Family Medicine · Chicago, ILNPI 1063659928

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $40,125 of the $63,562 with a category attached, or 63.1%. Tactile Systems Technology Inc accounts for 99.6% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $45,692 and has fallen 99.9% since, to $34 in 2023. Among family medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$63,562in general payments, 2019–2025

Across 77 payments — averaging $825.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tactile Systems Technology Inc$63K
  • Organogenesis Inc.$193
  • Smith+Nephew$17
  • Misonix Inc$12
  • GSK$11

What the payments were for

  • Consulting fees$11,00017%
  • Speaking & faculty fees$40,12563%
  • Travel & lodging$11,01817%
  • Food & beverage$1,0912%
  • Education$3281%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$63,562 in reported general payments places this provider in the 95th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$94,255
Medicare patients
233
Services billed
1,223

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Betamethasone Valerate14$401
Doxycycline Hyclate17$280
Triamcinolone Acetonide32$224

Paid to pharmacies, not to this prescriber.

Other family medicine in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →